Molecular mechanisms of drug transporter regulation

Handbook of Experimental Pharmacology

Volumn 201, Issue , 2011, Pages 373-402

  Tirona, Rommel G ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Gene expression; Nuclear receptors; Transcription factors; Variable drug response

Indexed keywords

ATORVASTATIN; CARBAMAZEPINE; CARRIER PROTEIN; CARVEDILOL; CONSTITUTIVE ANDROSTANE RECEPTOR; COUMARIN DERIVATIVE; DIGOXIN; DRUG TRANSPORTER; EZETIMIBE; FARNESOID X RECEPTOR; FEXOFENADINE; HYPERICUM PERFORATUM EXTRACT; KETOCONAZOLE; MIDAZOLAM; MULTIDRUG RESISTANCE PROTEIN 1; MYCOPHENOLIC ACID; OBETICHOLIC ACID; PHENOBARBITAL; PHENYTOIN; PIOGLITAZONE; PREDNISOLONE; PREGNANE X RECEPTOR; RIFAMPICIN; RIFAXIMIN; ROSIGLITAZONE; TALINOLOL; TROGLITAZONE; TUROFEXORATE ISOPROPYL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; CANCER RESISTANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG COMPETITION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG RESPONSE; DRUG TISSUE LEVEL; DRUG TRANSPORT; ENTERITIS; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HERITABILITY; HUMAN; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BIOLOGICAL TRANSPORT; DRUG INTERACTIONS; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; MEMBRANE TRANSPORT PROTEINS; PHARMACEUTICAL PREPARATIONS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION, GENETIC;

EID: 78649657340     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-14541-4_10     Document Type: Review

References (244)

1. Acocella G (1978) Clinical pharmacokinetics of rifampicin. Clin Pharmacokinet 3:108-127
2. Adesnik M, Bar-Nun S, Maschio F et al (1981) Mechanism of induction of cytochrome P-450 by phenobarbital. J Biol Chem 256:10340-10345
3. Albermann N, Schmitz-Winnenthal FH, Z'Graggen K et al (2005) Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem Pharmacol 70:949-958
4. Ananthanarayanan M, Balasubramanian N, Makishima M et al (2001) Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 276:28857-28865
5. Aninat C, Piton A, Glaise D et al (2006) Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos 34:75-83
6. Aoki M, Terada T, Ogasawara K et al (2009) Impact of regulatory polymorphisms in organic anion transporter genes in the human liver. Pharmacogenet Genomics 19:647-656
7. Assem M, Schuetz EG, Leggas M et al (2004) Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J Biol Chem 279:22250-22257
8. Auerbach SS, Ramsden R, Stoner MA et al (2003) Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res 31:3194-3207
9. Auerbach SS, Stoner MA, Su S et al (2005) Retinoid X receptor-alpha- dependent transactivation by a naturally occurring structural variant of human constitutive androstane receptor (NR1I3). Mol Pharmacol 68:1239-1253
10. Backman JT, Luurila H, Neuvonen M et al (2005) Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites. Clin Pharmacol Ther 78:154-167
11. Baes M, Gulick T, Choi HS et al (1994) A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol 14:1544-1551
12. Baker AR, McDonnell DP, Hughes M et al (1988) Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A 85:3294-3298
13. Barbier O, Torra IP, Sirvent A et al (2003) FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124:1926-1940
14. Bauer B, Hartz AM, Fricker G et al (2004) Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 66:413-419
15. Bauer B, Hartz AM, Lucking JR et al (2008) Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier. J Cereb Blood Flow Metab 28:1222-1234
16. Bauer B, Yang X, Hartz AM et al (2006) In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation. Mol Pharmacol 70:1212-1219
17. Benedetti MS (2000) Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies. Fundam Clin Pharmacol 14:301-319
18. Bertilsson G, Berkenstam A, Blomquist P (2001) Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7. Biochem Biophys Res Commun 280:139-144
19. Bertilsson G, Heidrich J, Svensson K et al (1998) Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci U S A 95:12208-12213
20. Blumberg B, Sabbagh W Jr, Juguilon H et al (1998) SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 12:3195-3205
21. Boyer JL, Trauner M, Mennone A et al (2006) Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. Am J Physiol Gastrointest Liver Physiol 290: G1124-G1130
22. Burbach KM, Poland A, Bradfield CA (1992) Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci U S A 89:8185-8189
23. Burk O, Arnold KA, Geick A et al (2005) A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol Chem 386:503-513
24. Burk O, Arnold KA, Nussler AK et al (2005) Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol 67:1954-1965
25. Carter BA, Taylor OA, Prendergast DR et al (2007) Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 62:301-306
26. Chawla A, Repa JJ, Evans RM et al (2001) Nuclear receptors and lipid physiology: opening the X-files. Science 294:1866-1870
27. Chen Y, Ferguson SS, Negishi M et al (2003) Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter. Mol Pharmacol 64:316-324
28. Chen Y, Ferguson SS, Negishi M et al (2004) Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. J Pharmacol Exp Ther 308:495-501
29. Chen Y, Teranishi K, Li S et al (2009) Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function. Pharmacogenomics J 9:127-136
30. Choi HS, Chung M, Tzameli I et al (1997) Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem 272:23565-23571
31. Conney AH, Jacobson M, Schneidman K et al (1965) Induction of liver microsomal cortisol 6betahydroxylase by diphenylhydantoin or phenobarbital: an explanation for the increased excretion of 6-hydroxycortisol in humans treated with these drugs. Life Sci 4:1091-1098
32. Cucinell SA, Koster R, Conney AH et al (1963) Stimulatory effect of phenobarbital on the metabolism of diphenylhydantoin. J Pharmacol Exp Ther 141:157-160
33. De Haan W, De Vries-van der Weij J, Mol IM et al (2009) PXR agonism decreases plasma HDL levels in ApoE3-Leiden. CETP mice. Biochim Biophys Acta 1791:191-197
34. Denson LA, Sturm E, Echevarria W et al (2001) The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121:140-147
35. DeVane CL (2003) Pharmacokinetics, drug interactions, and tolerability of valproate. Psychopharmacol Bull 37 (Suppl 2):25-42
36. Dotzlaw H, Leygue E, Watson P et al (1999) The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res 5:2103-2107
37. Dring MM, Goulding CA, Trimble VI et al (2006) The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 130:341-348, quiz 592
38. Drocourt L, Ourlin JC, Pascussi JM et al (2002) Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277:25125-25132
39. Drocourt L, Pascussi JM, Assenat E et al (2001) Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes. Drug Metab Dispos 29:1325-1331
40. Durr D, Stieger B, Kullak-Ublick GA et al (2000) St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 68:598-604
41. Dussault I, Beard R, Lin M et al (2003) Identification of gene-selective modulators of the bile acid receptor FXR. J Biol Chem 278:7027-7033
42. Dussault I, Yoo HD, Lin M et al (2003) Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proc Natl Acad Sci U S A 100:833-838
43. Echchgadda I, Song CS, Oh T et al (2007) The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4{alpha} in the regulation of human steroid-/bile acid-sulfotransferase. Mol Endocrinol 21:2099-2111
44. Echchgadda I, Song CS, Roy AK et al (2004) Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol Pharmacol 65:720-729
45. Evans MJ, Mahaney PE, Borges-Marcucci L et al (2009) A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia. Am J Physiol Gastrointest Liver Physiol 296: G543-G552
46. Fang HL, Strom SC, Ellis E et al (2007) Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4{alpha} and pregnane X receptor. J Pharmacol Exp Ther 323(2):586-598
47. Fenner KS, Troutman MD, Kempshall S et al (2009) Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug. Clin Pharmacol Ther 85:173-181
48. Ferguson SS, LeCluyse EL, Negishi M et al (2002) Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol Pharmacol 62:737-746
49. Figge A, Lammert F, Paigen B et al (2004) Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis. J Biol Chem 279:2790-2799
50. Finch CK, Chrisman CR, Baciewicz AM et al (2002) Rifampin and rifabutin drug interactions: an update. Arch Intern Med 162:985-992
51. Finkelstein D, Lamba V, Assem M et al (2006) ADME transcriptome in Hispanic versus White donor livers: evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics. Xenobiotica 36:989-1012
52. Flatt B, Martin R, Wang TL et al (2009) Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR). J Med Chem 52(4):904-907
53. Forman BM, Tzameli I, Choi HS et al (1998) Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 395:612-615
54. Fromm MF, Kauffmann HM, Fritz P et al (2000) The effect of rifampin treatment on intestinal expression of human MRP transporters. Am J Pathol 157:1575-1580
55. Fukuen S, Fukuda T, Matsuda H et al (2002) Identification of the novel splicing variants for the hPXR in human livers. Biochem Biophys Res Commun 298:433-438
56. Gallicano KD, Sahai J, Shukla VK et al (1999) Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients. Br J Clin Pharmacol 48:168-179
57. Gardner-Stephen D, Heydel JM, Goyal A et al (2004) Human PXR variants and their differential effects on the regulation of human UDP- glucuronosyltransferase gene expression. Drug Metab Dispos 32:340-347
58. Gartung C, Ananthanarayanan M, Rahman MA et al (1996) Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 110:199-209
59. Geick A, Eichelbaum M, Burk O (2001) Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276:14581-14587
60. Gerbal-Chaloin S, Daujat M, Pascussi JM et al (2002) Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J Biol Chem 277:209-217
61. Gerbal-Chaloin S, Pascussi JM, Pichard-Garcia L et al (2001) Induction of CYP2C genes inhuman hepatocytes in primary culture. Drug Metab Dispos 29:242-251
62. Giessmann T, Modess C, Hecker U et al (2004) CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects. Clin Pharmacol Ther 75:213-222
63. Gnerre C, Blattler S, Kaufmann MR et al (2004) Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. Pharmacogenetics 14:635-645
64. Goodwin B, Hodgson E, Liddle C (1999) The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 56:1329-1339
65. Goodwin B, Jones SA, Price RR et al (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517-526
66. Goodwin B, Moore LB, Stoltz CM et al (2001) Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol Pharmacol 60:427-431 (Pubitemid 32781548)
67. Greiner B, Eichelbaum M, Fritz P et al (1999) The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 104:147-153
68. Grover A, Benet LZ (2009) Effects of drug transporters on volume of distribution. AAPS J 11:250-261
69. Ha Choi J, Wah Yee S, Kim MJ et al (2009) Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1. Pharmacogenet Genomics 19:770-780
70. Hanley K, Jiang Y, Crumrine D et al (1997) Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest 100:705-712
71. Hariparsad N, Carr BA, Evers R et al (2008) Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction. Drug Metab Dispos 36:1046-1055
72. Hartman HB, Gardell SJ, Petucci CJ et al (2009) Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/-and apoE-/-mice. J Lipid Res 50(6):1090-1100
73. Hartz AM, Miller DS, Bauer B (2010) Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol Pharmacol 77:715-723
74. Hayashi A, Suzuki H, Itoh K et al (2003) Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochem Biophys Res Commun 310:824-829
75. Healan-Greenberg C, Waring JF, Kempf DJ et al (2008) A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane X receptor. Drug Metab Dispos 36:500-507
76. Hesselson SE, Matsson P, Shima JE et al (2009) Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation. PLoS ONE 4: e6942
77. Ho RH, Leake BF, Kilkenny DM et al (2010) Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability. Pharmacogenet Genomics 20:45-57
78. Ho RH, Tirona RG, Leake BF et al (2006) Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology 130:1793-1806
79. Hoekstra M, Lammers B, Out R et al (2009) Activation of the nuclear receptor PXR decreases plasma LDL-cholesterol levels and induces hepatic steatosis in LDL receptor knockout mice. Mol Pharm 6:182-189
80. Hoffman EC, Reyes H, Chu FF et al (1991) Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252:954-958
81. Honkakoski P, Zelko I, Sueyoshi T et al (1998) The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital- responsive enhancer module of the CYP2B gene. Mol Cell Biol 18:5652-5658
82. Hosseinpour F, Timsit Y, Koike C et al (2007) Overexpression of the Rho-guanine nucleotide exchange factor ECT2 inhibits nuclear translocation of nuclear receptor CAR in the mouse liver. FEBS Lett 581:4937-4942
83. Houten SM, Volle DH, Cummins CL et al (2007) In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue. Mol Endocrinol 21:1312-1323
84. Huang H, Wang H, Sinz M et al (2007) Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene 26:258-268
85. Huang W, Zhang J, Chua SS et al (2003) Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci U S A 100:4156-4161
86. Huang W, Zhang J, Moore DD (2004) A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J Clin Invest 113:137-143
87. Hustert E, Zibat A, Presecan-Siedel E et al (2001) Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metab Dispos 29:1454-1459
88. Huwyler J, Wright MB, Gutmann H et al (2006) Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin. Curr Drug Metab 7:119-126
89. Inoue K, Negishi M (2008) Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6 gene. J Biol Chem 283:10425-10432
90. Itoh M, Nakajima M, Higashi E et al (2006) Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-gamma coactivator 1alpha. J Pharmacol Exp Ther 319:693-702
91. Jiang H, Chen K, He J et al (2009) Association of pregnane X receptor with multidrug resistancerelated protein 3 and its role in human colon cancer chemoresistance. J Gastrointest Surg 13:1831-1838
92. Jigorel E, Le Vee M, Boursier-Neyret C et al (2006) Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 34:1756-1763
93. Jigorel E, Le Vee M, Boursier-Neyret C et al (2006) Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 34(10):1756-1763
94. Johne A, Brockmoller J, Bauer S et al (1999) Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 66:338-345
95. Jung D, Elferink MG, Stellaard F et al (2007) Analysis of bile acid-induced regulation of FXR target genes in human liver slices. Liver Int 27:137-144
96. Jung D, Podvinec M, Meyer UA et al (2002) Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology 122:1954-1966
97. Justesen US, Klitgaard NA, Brosen K et al (2003) Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers. Br J Clin Pharmacol 55:100-106
98. Kaeding J, Bouchaert E, Belanger J et al (2008) Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells. Biochem J 410:245-253
99. Kanebratt KP, Andersson TB (2008) HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans. Drug Metab Dispos 36:137-145
100. Kang MI, Kobayashi A, Wakabayashi N et al (2004) Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci U S A 101:2046-2051
101. Kast HR, Goodwin B, Tarr PT et al (2002) Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277:2908-2915
102. Kawamoto T, Sueyoshi T, Zelko I et al (1999) Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 19:6318-6322 (Pubitemid 29399336)
103. Kikuchi R, Kusuhara H, Hattori N et al (2006) Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha/beta and DNA methylation. Mol Pharmacol 70:887-896
104. King JR, Acosta EP (2006) Tipranavir: a novel nonpeptidic protease inhibitor of HIV. Clin Pharmacokinet 45:665-682
105. Kliewer SA, Moore JT, Wade L et al (1998) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92:73-82
106. Kobayashi K, Yamanaka Y, Iwazaki N et al (2005) Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor. Drug Metab Dispos 33:924-929
107. Kocarek TA, Schuetz EG, Strom SC et al (1995) Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metab Dispos 23:415-421
108. Kong B, Luyendyk JP, Tawfik O et al (2009) Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet. J Pharmacol Exp Ther 328:116-122
109. Kovacs P, Kress R, Rocha J et al (2008) Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J Hepatol 48:116-124
110. Koyano S, Kurose K, Ozawa S et al (2002) Eleven novel single nucleotide polymorphisms in the NR1I2 (PXR) gene, four of which induce non-synonymous amino acid alterations. Drug Metab Pharmacokinet 17:561-565
111. Kreisl WC, Liow JS, Kimura N et al (2010) P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide. J Nucl Med 51:559-566
112. Kwak MK, Wakabayashi N, Itoh K et al (2003) Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem 278:8135-8145
113. Lamba J, Lamba V, Strom S et al (2008) Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression. Drug Metab Dispos 36:169-181
114. Lamba JK, Lamba V, Yasuda K et al (2004) Expression of CAR splice variants in human tissues and their functional consequences. J Pharmacol Exp Ther 311(2):811-821
115. Lamba V, Lamba J, Yasuda K et al (2003) Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther 307:906-922
116. Lamba V, Yasuda K, Lamba JK et al (2004) PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol 199:251-265
117. Lambert CB, Spire C, Claude N et al (2009) Dose-and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol 234:345-360
118. Lambert CB, Spire C, Renaud MP et al (2009) Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro 23:466-475
119. Landrier JF, Eloranta JJ, Vavricka SR et al (2006) The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and-beta genes. Am J Physiol Gastrointest Liver Physiol 290: G476-G485
120. Langmade SJ, Gale SE, Frolov A et al (2006) Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc Natl Acad Sci U S A 103:13807-13812
121. Langmann T, Moehle C, Mauerer R et al (2004) Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 127:26-40
122. Lee YJ, Maeda J, Kusuhara H et al (2006) In vivo evaluation of P-glycoprotein function at the bloodbrain barrier in nonhuman primates using [11C]verapamil. J Pharmacol Exp Ther 316:647-653 (Pubitemid 43130991)
123. Lehmann JM, McKee DD, Watson MA et al (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016-1023
124. Li L, Chen T, Stanton JD et al (2008) The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol 74:443-453
125. Li YT, Swales KE, Thomas GJ et al (2007) Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration. Arterioscler Thromb Vasc Biol 27:2606-2611
126. Lim YP, Liu CH, Shyu LJ et al (2005) Functional characterization of a novel polymorphism of pregnane X receptor, Q158K, in Chinese subjects. Pharmacogenet Genomics 15:337-341
127. Lin YS, Lockwood GF, Graham MA et al (2001) In-vivo phenotyping for CYP3A by a singlepoint determination of midazolam plasma concentration. Pharmacogenetics 11:781-791
128. Lin YS, Yasuda K, Assem M et al (2009) The major human pregnane X receptor (PXR) splice variant, PXR.2, exhibits significantly diminished ligand-activated transcriptional regulation. Drug Metab Dispos 37:1295-1304
129. Liu Y, Ji W, Yin Y et al (2009) The effects of splicing variant of PXR PAR-2 on CYP3A4 and MDR1 mRNA expressions. Clin Chim Acta 403:142-144
130. Lloyd P, Flesch G, Dieterle W (1994) Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia 35 (Suppl 3): S10-S13
131. Luo G, Cunningham M, Kim S et al (2002) CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos 30:795-804
132. Ma X, Shah YM, Guo GL et al (2007) Rifaximin is a gut-specific human pregnane X receptor activator. J Pharmacol Exp Ther 322:391-398
133. Maglich JM, Lobe DC, Moore JT (2009) The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress. J Lipid Res 50:439-445
134. Maglich JM, Parks DJ, Moore LB et al (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 278:17277-17283
135. Makishima M, Lu TT, Xie W et al (2002) Vitamin D receptor as an intestinal bile acid sensor. Science 296:1313-1316
136. Makishima M, Okamoto AY, Repa JJ et al (1999) Identification of a nuclear receptor for bile acids. Science 284:1362-1365
137. Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83:841-850
138. Mani S, Huang H, Sundarababu S et al (2005) Activation of the steroid and xenobiotic receptor (human pregnane X receptor) by nontaxane microtubule-stabilizing agents. Clin Cancer Res 11:6359-6369
139. Marzolini C, Tirona RG, Gervasini G et al (2007) A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression. Mol Endocrinol 21:1769-1780
140. Masson D, Lagrost L, Athias A et al (2005) Expression of the pregnane X receptor in mice antagonizes the cholic acid-mediated changes in plasma lipoprotein profile. Arterioscler Thromb Vasc Biol 25:2164-2169
141. McCarthy TC, Li X, Sinal CJ (2005) Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids. J Biol Chem 280:23232-23242
142. McGinnity DF, Zhang G, Kenny J et al (2009) Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: human hepatocytes, PXR reporter gene, Fa2N-4 and HepaRG cells. Drug Metab Dispos 37(6):1259-1268
143. Meier Y, Pauli-Magnus C, Zanger UM et al (2006) Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology 44:62-74
144. Mencarelli A, Renga B, Distrutti E et al (2009) Antiatherosclerotic effect of farnesoid X receptor. Am J Physiol Heart Circ Physiol 296: H272-H281
145. Merrell MD, Jackson JP, Augustine LM et al (2008) The Nrf2 activator oltipraz also activates the constitutive androstane receptor. Drug Metab Dispos 36:1716-1721
146. Meyer zu Schwabedissen HE, Tirona RG, Yip CS et al (2008) Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res 68:9338-9347
147. Miki Y, Suzuki T, Kitada K et al (2006) Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. Cancer Res 66:535-542
148. Mills JB, Rose KA, Sadagopan N et al (2004) Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line. J Pharmacol Exp Ther 309:303-309
149. Miura M, Satoh S, Inoue K et al (2008) Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients. Steroids 73:1052-1059
150. Miyata M, Matsuda Y, Tsuchiya H et al (2006) Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase. Drug Metab Pharmacokinet 21:315-323
151. Mizuarai S, Aozasa N, Kotani H (2004) Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2. Int J Cancer 109:238-246
152. Moore LB, Goodwin B, Jones SA et al (2000) St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A 97:7500-7502
153. Moore LB, Parks DJ, Jones SA et al (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122-15127
154. Moschetta A, Bookout AL, Mangelsdorf DJ (2004) Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 10:1352-1358
155. Mouly S, Lown KS, Kornhauser D et al (2002) Hepatic but not intestinal CYP3A4 displays dosedependent induction by efavirenz in humans. Clin Pharmacol Ther 72:1-9
156. Murphy RL, Sommadossi JP, Lamson M et al (1999) Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1. J Infect Dis 179:1116-1123
157. Naesens M, Kuypers DR, Streit F et al (2006) Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients. Clin Pharmacol Ther 80:509-521
158. Narang VS, Fraga C, Kumar N et al (2008) Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. Am J Physiol Cell Physiol 295: C440-C450
159. Nguyen T, Huang HC, Pickett CB (2000) Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J Biol Chem 275:15466-15473
160. Nies AT, Koepsell H, Winter S et al (2009) Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology 50:1227-1240
161. Ohtsuka H, Abe T, Onogawa T et al (2006) Farnesoid X receptor, hepatocyte nuclear factors 1alpha and 3beta are essential for transcriptional activation of the liver-specific organic anion transporter-2 gene. J Gastroenterol 41:369-377
162. Olinga P, Elferink MG, Draaisma AL et al (2008) Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. Eur J Pharm Sci 33:380-389
163. Oscarson M, Zanger UM, Rifki OF et al (2006) Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther 80:440-456
164. Oswald S, Haenisch S, Fricke C et al (2006) Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans. Clin Pharmacol Ther 79:206-217
165. Owen A, Goldring C, Morgan P et al (2005) Relationship between the C3435T and G2677T (A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver. Br J Clin Pharmacol 59:365-370
166. Parks DJ, Blanchard SG, Bledsoe RK et al (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365-1368
167. Pascussi JM, Drocourt L, Gerbal-Chaloin S et al (2001) Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur J Biochem 268:6346-6358
168. Pascussi JM, Jounaidi Y, Drocourt L et al (1999) Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene. Biochem Biophys Res Commun 260:377-381
169. Paulusma CC, Kool M, Bosma PJ et al (1997) A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 25:1539-1542
170. Perloff ES, Duan SX, Skolnik PR et al (2005) Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro. Drug Metab Dispos 33:764-770
171. Plass JR, Mol O, Heegsma J et al (2002) Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 35:589-596
172. Poland A, Glover E, Kende AS (1976) Stereospecific, high affinity binding of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem 251:4936-4946
173. Qureshi GD, Reinders TP, Somori GJ et al (1984) Warfarin resistance with nafcillin therapy. Ann Intern Med 100:527-529
174. Raucy J, Warfe L, Yueh MF et al (2002) A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system. J Pharmacol Exp Ther 303:412-423
175. Remmer H, Schoene B, Fleischmann RA (1973) Induction of the unspecific microsomal hydroxylase in the human liver. Drug Metab Dispos 1:224-230
176. Ricketts ML, Boekschoten MV, Kreeft AJ et al (2007) The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Mol Endocrinol 21:1603-1616
177. Ripp SL, Mills JB, Fahmi OA et al (2006) Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction. Drug Metab Dispos 34:1742-1748
178. Ruschitzka F, Meier PJ, Turina M et al (2000) Acute heart transplant rejection due to Saint John's wort. Lancet 355:548-549
179. Saeki M, Kurose K, Tohkin M et al (2008) Identification of the functional vitamin D response elements in the human MDR1 gene. Biochem Pharmacol 76:531-542
180. Sandanaraj E, Lal S, Selvarajan V et al (2008) PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients. Clin Cancer Res 14:7116-7126
181. Sasongko L, Link JM, Muzi M et al (2005) Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography. Clin Pharmacol Ther 77:503-514
182. Scheer N, Ross J, Rode A et al (2008) A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. J Clin Invest 118:3228-3239
183. Schmiedlin-Ren P, Thummel KE, Fisher JM et al (1997) Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha, 25-dihydroxyvitamin D3. Mol Pharmacol 51:741-754
184. Schoene B, Fleischmann RA, Remmer H et al (1972) Determination of drug metabolizing enzymes in needle biopsies of human liver. Eur J Clin Pharmacol 4:65-73
185. Schuetz E, Lan L, Yasuda K et al (2002) Development of a real-time in vivo transcription assay: application reveals pregnane X receptor-mediated induction of CYP3A4 by cancer chemotherapeutic agents. Mol Pharmacol 62:439-445
186. Schuetz EG, Beck WT, Schuetz JD (1996) Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 49:311-318
187. Schuetz EG, Furuya KN, Schuetz JD (1995) Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 275:1011-1018
188. Schuetz EG, Schinkel AH, Relling MV et al (1996) P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Proc Natl Acad Sci U S A 93:4001-4005
189. Schuetz EG, Strom S, Yasuda K et al (2001) Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 276:39411-39418 (Pubitemid 37371319)
190. Schwarz UI, Hanso H, Oertel R et al (2007) Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol. Clin Pharmacol Ther 81:669-678
191. Shah YM, Ma X, Morimura K et al (2007) Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. Am J Physiol Gastrointest Liver Physiol 292: G1114-G1122
192. Shin HJ, Lee CH, Lee SS et al (2010) Identification of genetic polymorphisms of human OAT1 and OAT2 genes and their relationship to hOAT2 expression in human liver. Clin Chim Acta 411:99-105
193. Shulman AI, Larson C, Mangelsdorf DJ et al (2004) Structural determinants of allosteric ligand activation in RXR heterodimers. Cell 116:417-429
194. Siccardi M, D'Avolio A, Baietto L et al (2008) Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-
195. Siest G, Jeannesson E, Marteau JB et al (2008) Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug Metab Dispos 36:182-189
196. Simon C, Stieger B, Kullak-Ublick GA et al (2007) Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition. Acta Neurol Scand 115:232-242
197. Sookoian S, Castano GO, Burgueno AL et al (2010) The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease. Pharmacogenet Genomics 20:1-8
198. Sporstol M, Tapia G, Malerod L et al (2005) Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I. Biochem Biophys Res Commun 331:1533-1541
199. Strautnieks SS, Bull LN, Knisely AS et al (1998) A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 20:233-238
200. Strautnieks SS, Byrne JA, Pawlikowska L et al (2008) Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 134:1203-1214
201. Sueyoshi T, Kawamoto T, Zelko I et al (1999) The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274:6043-6046
202. Sueyoshi T, Moore R, Sugatani J et al (2008) PPP1R16A, the membrane subunit of protein phosphatase 1beta, signals nuclear translocation of the nuclear receptor constitutive active/androstane receptor. Mol Pharmacol 73:1113-1121
203. Sugatani J, Kojima H, Ueda A et al (2001) The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33:1232-1238
204. Sugatani J, Yamakawa K, Tonda E et al (2004) The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem Pharmacol 67:989-1000
205. Suino K, Peng L, Reynolds R et al (2004) The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol Cell 16:893-905
206. Synold TW, Dussault I, Forman BM (2001) The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7:584-590
207. Teng S, Jekerle V, Piquette-Miller M (2003) Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab Dispos 31:1296-1299
208. Thummel KE, Brimer C, Yasuda K et al (2001) Transcriptional control of intestinal cytochrome P-4503A by 1alpha, 25-dihydroxy vitamin D3. Mol Pharmacol 60:1399-1406
209. Tirona RG, Kim RB (2005) Nuclear receptors and drug disposition gene regulation. J Pharm Sci 94:1169-1186
210. Tirona RG, Kim RB (2009) Nuclear receptors and drug-drug interactions with prescription and herbal medicines. In: Xie W (ed) Nuclear receptors in drug metabolism. Wiley, Hoboken, NJ
211. Tirona RG, Leake BF, Merino G et al (2001) Polymorphisms in OATP-C. Identification of multiple allelic variants associated with altered transport activity among European-and African-Americans. J Biol Chem 276:35669-35675
212. Tirona RG, Leake BF, Podust LM et al (2004) Identification of amino acids in rat pregnane X receptor that determine species-specific activation. Mol Pharmacol 65:36-44
213. Tirona RG, Leake BF, Wolkoff AW et al (2003) Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther 304:223-228
214. Toornvliet R, van Berckel BN, Luurtsema G et al (2006) Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11) C]verapamil and positron emission tomography. Clin Pharmacol Ther 79:540-548
215. Toyohara T, Suzuki T, Morimoto R et al (2009) SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. J Am Soc Nephrol 20:2546-2555
216. Urizar NL, Liverman AB, Dodds DT et al (2002) A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 296:1703-1706
217. Urquhart BL, Ware JA, Tirona RG et al (2008) Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe. Pharmacogenet Genomics 18:439-448
218. van Giersbergen PL, Gnerre C, Treiber A et al (2002) Bosentan, a dual endothelin receptor antagonist, activates the pregnane X nuclear receptor. Eur J Pharmacol 450:115-121
219. Van Mil SW, Milona A, Dixon PH et al (2007) Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 133:507-516
220. Venugopal R, Jaiswal AK (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD (P) H:quinone oxidoreductase1 gene. Proc Natl Acad Sci U S A 93:14960-14965
221. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD et al (2004) Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci U S A 101:2040-2045
222. Wang H, Chen J, Hollister K et al (1999) Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3:543-553
223. Wang H, Faucette S, Sueyoshi T et al (2003) A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem 278:14146-14152
224. Wang H, Faucette SR, Moore R et al (2004) Human CAR mediates induction of CYP2B6 gene expression by phenytoin. J Biol Chem 279:29295-29301
225. Wang H, Huang H, Li H et al (2007) Activated pregnenolone X-receptor is a target for ketoconazole and its analogs. Clin Cancer Res 13:2488-2495
226. Wang H, Li H, Moore LB et al (2008) The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptor. Mol Endocrinol 22:838-857
227. Wang YD, Chen WD, Wang M et al (2008) Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology 48:1632-1643
228. Watkins RE, Davis-Searles PR, Lambert MH et al (2003) Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J Mol Biol 331:815-828
229. Watkins RE, Maglich JM, Moore LB et al (2003) 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry 42:1430-1438
230. Watkins RE, Wisely GB, Moore LB et al (2001) The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292:2329-2333
231. Westlind-Johnsson A, Malmebo S, Johansson A et al (2003) Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. Drug Metab Dispos 31:755-761
232. Wilkinson GR (2005) Drug metabolism and variability among patients in drug response. N Engl J Med 352:2211-2221
233. Xie W, Barwick JL, Downes M et al (2000) Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406:435-439
234. Xu RX, Lambert MH, Wisely BB et al (2004) A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol Cell 16:919-928
235. Yamazaki Y, Kakizaki S, Horiguchi N et al (2007) The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis. Gut 56:565-574
236. Yang J, Yan B (2007) Photochemotherapeutic agent 8-methoxypsoralen induces cytochrome P450 3A4 and carboxylesterase HCE2: evidence on an involvement of the pregnane X receptor. Toxicol Sci 95:13-22
237. Yasuda K, Ranade A, Venkataramanan R et al (2008) A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine. Drug Metab Dispos 36:1689-1697
238. Zamber CP, Lamba JK, Yasuda K et al (2003) Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics 13:19-28
239. Zastre JA, Chan GN, Ronaldson PT et al (2009) Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line. J Neurosci Res 87:1023-1036
240. Zhang J, Kuehl P, Green ED et al (2001) The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 11:555-572
241. Zhang S, Liu Q, Wang J et al (2009) Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists. Biochem Biophys Res Commun 379:476-479
242. Zhou C, Poulton EJ, Grun F et al (2007) The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Pharmacol 71:220-229
243. Zhou C, Tabb MM, Nelson EL et al (2006) Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest 116:2280-2289
244. Zhou J, Liu M, Zhai Y et al (2008) The antiapoptotic role of pregnane X receptor in human colon cancer cells. Mol Endocrinol 22:868-880